Impact of anti-rheumatic treatment on immunogenicity of pandemic H1N1 influenza vaccine in patients with arthritis

INTRODUCTION: An adjuvanted pandemic H1N1 influenza (pH1N1) vaccine (Pandemrix®) was reported as highly immunogenic resulting in seroconversion in 77 to 94% of adults after administration of a single dose. The aim of the study was to investigate the impact of different anti-rheumatic treatments on a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kapetanovic, Meliha C, Kristensen, Lars-Erik, Saxne, Tore, Aktas, Teodora, Mörner, Andreas, Geborek, Pierre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978632/
https://www.ncbi.nlm.nih.gov/pubmed/24383620
http://dx.doi.org/10.1186/ar4427

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978632/
https://www.ncbi.nlm.nih.gov/pubmed/24383620
http://dx.doi.org/10.1186/ar4427

Ejemplares similares